Colossal Acquires Viagen to Scale Species Recovery

Colossal Biosciences has acquired Viagen Pets & Equine, integrating industry-leading reproductive services, cryopreservation, and cell banking into Colossal’s conservation platform. Viagen will operate as a wholly owned subsidiary, continuing its pet, equine, and livestock services while partnering with Colossal on endangered-species programs and upcoming BioVaults initiatives. The move strengthens Colossal’s end-to-end toolkit—spanning ancient DNA assembly, comparative genomics, genome engineering, assisted reproduction, and long-term preservation—so projects can move from research to real-world species recovery faster. With shared expertise, expanded capacity, and proven methodologies, the combined team aims to scale practical, science-driven solutions that preserve biodiversity and protect critical genetic resources worldwide.

Full feature on ScreenRant